Eylea | search
Click here to view Eylea news from 60+ newspapers.
Bookmark or Share- Eye Injections for Retinal Diseases | EYLEA® (aflibercept) InjectionIndications. EYLEA® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Retinopathy of Prematurity (ROP) (0.4 mg). Please see the full ...
- Eylea: Side Effects, Cost, How It's Given, and More - HealthlineDrug Images. Eylea (aflibercept) is a biologic drug prescribed to help prevent vision loss in certain situations. It’s a liquid solution given by healthcare professionals as an injection into the...
- Eylea & Eylea HD Injection: Uses, Dosage & Side Effects - Drugs.comEylea is an injectable eye preparation that is given by a healthcare provider every one to two months that may be used to treat the following conditions: Neovascular (Wet) Age-Related Macular Degeneration (AMD) – a condition where new blood vessels grow under the retina where they leak blood and fluid.
- Eylea: 7 things you should know - Drugs.comEylea (aflibercept 2 mg/0.05 mL injection) from Regeneron was first approved by the FDA in 2011 to treat five different eye diseases driven by VEGF-inhibition that may affect vision loss, including: Neovascular (Wet) Age-Related Macular Degeneration (nAMD) Diabetic macular edema (DME) Diabetic retinopathy (DR)
- EYLEA HD (aflibercept) | Official Patient WebsiteEYLEA HD provided significant vision improvement. EYLEA HD helped 83% of patients with Wet AMD and 93% with DME go 3 or 4 months between treatments. after 3 initial monthly treatments* EYLEA HD may provide noticeable improvements on your retinal imaging. that you and your retina specialist can see.
More
